de Vries, Julius
Vermue, Dannie J.
Sidorenkov, Grigory
Festen, Suzanne
Langendijk, Johannes A.
de Bock, Geertruida H.
Halmos, Gyorgy B. http://orcid.org/0000-0003-2460-2260
Article History
Received: 11 September 2023
Accepted: 5 February 2024
First Online: 1 March 2024
Declarations
:
: JAL declared receiving Grants from the European Union and Dutch Cancer Society, receiving consulting fees and honorarium from IBA, paid to UMCG Research BV, receiving research grants from IBA, RaySearch, Elekta, Mirada and Siemens, serving in the monitoring or advisory board of UMCN, IBA and RaySearch, and serving as chair of the NVRO. The other authors reported no disclosures.
: This study [the Oncological Life Study (OncoLifeS)], a large hospital-based oncological data-biobank at the University Medical Center Groningen (UMCG), Groningen, The Netherlands, OncoLifeS has been approved by the medical ethics committee of the UMCG (no. 2010/109) and has been ISO certified (9001:2008 Healthcare). It was registered in the Dutch Trial Register under the number: NL7839.
: Patients were included after obtaining written informed consent.